Astera Labs, Inc. $ALAB Shares Acquired by Silvant Capital Management LLC

Silvant Capital Management LLC grew its holdings in Astera Labs, Inc. (NASDAQ:ALAB) by 85.1% in the 4th quarter, Holdings Channel reports. The institutional investor owned 20,798 shares of the company’s stock after buying an additional 9,561 shares during the quarter. Silvant Capital Management LLC’s holdings in Astera Labs were worth $3,460,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Eurizon Capital SGR S.p.A. acquired a new stake in shares of Astera Labs in the 4th quarter valued at approximately $18,708,000. Nordea Investment Management AB acquired a new stake in shares of Astera Labs in the 4th quarter valued at approximately $2,028,000. Geneva Partners LLC acquired a new stake in shares of Astera Labs in the 3rd quarter valued at approximately $1,876,000. Swedbank AB lifted its holdings in shares of Astera Labs by 76.8% in the 4th quarter. Swedbank AB now owns 78,140 shares of the company’s stock valued at $12,999,000 after buying an additional 33,940 shares during the period. Finally, Numerai GP LLC raised its holdings in Astera Labs by 153.1% during the third quarter. Numerai GP LLC now owns 13,212 shares of the company’s stock worth $2,587,000 after purchasing an additional 7,992 shares during the last quarter. 60.47% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Astera Labs

In other news, Director Manuel Alba sold 183,000 shares of the business’s stock in a transaction on Wednesday, April 1st. The stock was sold at an average price of $107.61, for a total value of $19,692,630.00. Following the completion of the transaction, the director directly owned 319,863 shares of the company’s stock, valued at $34,420,457.43. The trade was a 36.39% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 400,000 shares of the business’s stock in a transaction on Thursday, May 21st. The stock was sold at an average price of $290.30, for a total value of $116,120,000.00. Following the completion of the transaction, the chief operating officer directly owned 5,064,213 shares of the company’s stock, valued at approximately $1,470,141,033.90. This trade represents a 7.32% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 2,161,256 shares of company stock valued at $459,844,296 over the last three months. 10.40% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the company. Barclays lifted their price objective on Astera Labs from $165.00 to $200.00 and gave the stock an “equal weight” rating in a report on Thursday, May 7th. JPMorgan Chase & Co. lifted their price objective on Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a report on Wednesday, May 6th. Susquehanna lifted their price objective on Astera Labs from $155.00 to $230.00 and gave the stock a “neutral” rating in a report on Wednesday, May 6th. Stifel Nicolaus lifted their price objective on Astera Labs from $236.00 to $260.00 and gave the stock a “buy” rating in a report on Wednesday, May 6th. Finally, Roth Mkm reaffirmed a “buy” rating and set a $275.00 price objective on shares of Astera Labs in a report on Wednesday, May 6th. Twelve investment analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $233.75.

Astera Labs Stock Up 6.0%

NASDAQ ALAB opened at $389.20 on Tuesday. Astera Labs, Inc. has a fifty-two week low of $84.78 and a fifty-two week high of $398.13. The stock has a market cap of $66.71 billion, a price-to-earnings ratio of 262.97, a price-to-earnings-growth ratio of 4.86 and a beta of 3.94. The business has a fifty day moving average of $242.61 and a 200-day moving average of $180.88.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The company had revenue of $308.36 million during the quarter, compared to analysts’ expectations of $292.19 million. During the same period in the previous year, the firm posted $0.33 earnings per share. The business’s revenue for the quarter was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, analysts anticipate that Astera Labs, Inc. will post 1.84 EPS for the current year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.